17 December 2024
PharmaPatents
USPTO Drops Proposed Rules on Terminal Disclaimers
Earlier in 2024, the U.S. Patent and Trademark Office proposed a sweeping set of rules imposing new requirements on terminal disclaimers filed to overcome obviousness-type double patenting rejections, and separately proposed to impose new terminal disclaimer fees that would increase exponentially over the course of examination.